TUBERCULOSIS SITUATION IN 2020
KENYA
Population: 53,771,300
Lower middle-income
NA
estimated people who developed Drug Resistant TB (DR-TB) - a form of TB more difficult to diagnose, treat and cure (WHO TB Database)
TB is the number 4
cause of death among communicable, maternal, neonatal & nutritional diseases(IHME Global Burden of Disease, 2020)
TB, 2010-2020
Drug Resistant TB, 2010-2020
TB-HIV Co-infection, 2010-2020
UNHLM Diagnosis and Treatment Targets
Click on greyed legend icons to access values for DR-TB/Pediatric TB
UNHLM TB Preventive Therapy Targets
Click on greyed legend icons to access values for PLHIV/Children
Resources Needed to reach UNHLM Targets Resources include Health System Cost and Enablers
Due to the Covid pandemics, needs are likely to increase in 2021-2022
Undernourishment
HIV
Living in Slums
Diabetes
NA values indicate missing data
Available TB Funding (US$ Millions), 2011-2020TB Funding excludes Health System Cost
Available Funding: Sources & Category, 2020
TB REACH Grants (US$ Cummulative)(2011-2020)
Diagnostics and Medicines supplied by GDF
(including New Drugs and Regimens)
Progress Related to Global Plan Targets
Reach at least 90% of people with TB
Successfully treat at least 90% of notified people with TB
Country Membership & Eligibility
Yes(Y)/No(N)
- Is High TB Burden? Y
- Is High DR-TB Burden? N
- Is High TB-HIV Burden? Y
- Eligible for Global Fund Funding (TB or TB/HIV)? Y
- Participates in GF Strategic Initiative to find missing people with TB? Y
- Active national TB MP Caucus? Y
- National StopTB Partnership? Y
- USAID TB Priority? NA